A Newly Established Murine Cell Line as a Model for Hepatocellular Cancer in Non-Alcoholic Steatohepatitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.3390/ijms20225658
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2019
- Urheber
-
Kroh, Andreas
Walter, Jeanette
Schüler, Herdit
Nolting, Jochen
Eickhoff, Roman Marius
Heise, Daniel
Neumann, Ulf Peter
Cramer, Thorsten
Ulmer, Tom Florian
Fragoulis, Athanassios
- DOI
-
10.18154/RWTH-2020-02154
- URN
-
urn:nbn:de:101:1-2021101806460422347123
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kroh, Andreas
- Walter, Jeanette
- Schüler, Herdit
- Nolting, Jochen
- Eickhoff, Roman Marius
- Heise, Daniel
- Neumann, Ulf Peter
- Cramer, Thorsten
- Ulmer, Tom Florian
- Fragoulis, Athanassios
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2019
Ähnliche Objekte (12)
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
The influence of mTOR inhibition on the pathogenesis of non-alcoholic steatohepatitis derived hepatocellular carcinoma
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
The influence of mTOR inhibition on the pathogenesis of non-alcoholic steatohepatitis derived hepatocellular carcinoma
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis
The role of formyl peptide receptor 2 in the development of non-alcoholic steatohepatitis
A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis
A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma
The influence of mTOR inhibition on the pathogenesis of non-alcoholic steatohepatitis derived hepatocellular carcinoma
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
Transaminase concentrations cannot separate non-alcoholic fatty liver and non-alcoholic steatohepatitis in morbidly obese patients irrespective of histological algorithm
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis
The role of formyl peptide receptor 1 in the development of non-alcoholic steatohepatitis
ω‐Imidazolyl‐alkyl derivatives as new preclinical drug candidates for treating non‐alcoholic steatohepatitis
Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis